Drug intelligence / Profile preview

Ruishuan

Development stage
Unknown
Lead developer
Henan Lingrui Pharmaceutical
Modality
Small Molecules
Administration
Transdermal
01

Overview

Ruishuan is a fentanyl transdermal patch developed and manufactured by Henan Lingrui Pharmaceutical for the management of severe pain, including chronic cancer pain and postoperative analgesia. Fentanyl is a potent synthetic small molecule opioid that functions as a selective agonist of the μ-opioid receptor (MOR) within the central nervous system. By binding to these receptors, it inhibits ascending pain pathways, alters the perception of and response to pain, and increases the pain threshold. The Ruishuan formulation utilizes a fentanyl-in-matrix technology for controlled, transdermal delivery of the active ingredient over a multi-day period. Henan Lingrui is one of the few licensed producers of narcotic analgesics in China, maintaining specialized divisions for fentanyl and transdermal patch production.

Brand names
Ruishuan瑞栓
Other names
fentanyl transdermal patch芬太尼透皮贴剂Lingrui fentanyl patch
02

Targets

MOR (Mu opioid receptor)

Beyond the preview

Go deeper on Ruishuan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ruishuan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call